FeetMe is a French medtech company specializing in wearable gait analysis and mobility assessment solutions. The company develops smart insoles equipped with sensors and wireless connectivity that allow healthcare professionals to monitor, assess, and improve patients’ walking patterns and postural stability in real time.
Designed for use in clinical settings, rehabilitation centers, and even home-based care, FeetMe’s technology combines sensor-based hardware with intelligent software to provide actionable insights into a patient’s gait. It supports clinicians in diagnosing mobility disorders, monitoring progress during recovery, and optimizing rehabilitation protocols.
FeetMe’s mission is to revolutionize the way movement disorders and rehabilitation outcomes are assessed, using wearable technology and digital biomarkers to make mobility measurement more accessible, precise, and continuous.
Features
FeetMe’s core technology includes FeetMe Monitor and FeetMe Evaluation, both centered around a smart insole system embedded with multiple motion sensors. These insoles are designed to fit inside a patient’s existing footwear and collect detailed biomechanical data during walking.
The insoles feature pressure sensors, accelerometers, and gyroscopes that capture key gait parameters such as step length, cadence, walking speed, ground contact time, asymmetry, and postural stability. The data is transmitted wirelessly in real time to a connected application on a tablet or computer.
FeetMe Evaluation, the clinical solution, provides detailed gait analysis and visual reports. Clinicians can view gait cycles, performance trends, and movement deviations, helping them make informed decisions during diagnosis or treatment.
Another key feature is remote patient monitoring. FeetMe’s platform allows for data collection outside clinical settings, making it ideal for follow-up assessments and home-based rehabilitation. The system ensures high patient adherence due to its discreet, comfortable design.
The platform also includes data dashboards and automated report generation, saving time for practitioners and improving documentation for patient records and insurance claims.
How It Works
FeetMe’s solution starts with a pair of smart insoles that are placed inside a patient’s shoes. Once worn, the insoles continuously record movement-related data using embedded pressure and motion sensors.
This data is streamed in real time to the FeetMe mobile or desktop application, where the software processes and visualizes the metrics. The system evaluates each gait cycle and presents the information in an intuitive format for clinicians or therapists to review.
Clinicians can assess deviations from normal walking patterns, measure rehabilitation progress, and tailor treatment plans accordingly. The platform allows for both supervised and unsupervised assessments, meaning it can be used in a hospital setting or during daily activities at home.
The combination of hardware and software provides a digital gait lab experience without the need for bulky or expensive motion capture systems.
Use Cases
FeetMe is widely used in neurological rehabilitation, particularly for conditions such as Parkinson’s disease, multiple sclerosis, and stroke recovery. The technology helps clinicians monitor improvements or deteriorations in motor control and adjust therapy in real time.
In orthopedic and post-surgical rehabilitation, FeetMe supports recovery from injuries or surgeries involving the lower limbs. Clinicians can track weight-bearing symmetry, walking confidence, and return-to-mobility milestones.
FeetMe is also used in geriatrics and fall prevention programs, where mobility and balance tracking are crucial. The insoles help detect early signs of instability or irregular gait, allowing intervention before a fall occurs.
In clinical trials and research, FeetMe’s platform is used for collecting objective digital biomarkers for mobility-related endpoints, ensuring reliable and quantifiable data collection in real-world environments.
Sports medicine and elite athlete training programs may also benefit from FeetMe’s granular movement analysis, although the core focus remains on clinical rehabilitation and monitoring.
Pricing
FeetMe does not list its pricing publicly on its website. Pricing likely varies based on whether the product is being deployed in a clinical practice, hospital, or research institution. Costs may also depend on the number of insoles, licenses, and the level of software integration or support services required.
The company offers customized solutions and recommends contacting their team directly for quotes and demonstrations tailored to specific organizational needs.
Strengths
One of FeetMe’s main strengths is its ability to deliver real-time, high-precision gait analysis in a portable and non-intrusive format. Unlike traditional gait labs that require expensive equipment and scheduled assessments, FeetMe enables continuous monitoring in any setting.
The insoles are discreet and easy to use, increasing patient comfort and compliance. The real-time feedback and remote monitoring capabilities provide clinicians with a more complete picture of the patient’s condition over time, rather than relying on snapshot evaluations.
FeetMe’s system supports objective decision-making, reducing reliance on subjective assessments and improving the accuracy of diagnosis and treatment planning.
Its regulatory compliance (CE-marked) and strong focus on research-backed development make it a trusted solution in clinical and academic environments.
Drawbacks
One limitation is the lack of publicly available pricing information, which may make it difficult for smaller clinics or individual practitioners to evaluate affordability.
Another potential drawback is the reliance on compatible hardware, such as tablets or computers, to fully leverage the data visualization and analysis tools. Institutions may need to invest in compatible devices and provide training for optimal usage.
FeetMe’s solutions are specialized and may not yet support broader health monitoring features outside gait and posture, which could be a consideration for clinics looking for an all-in-one wearable health platform.
Finally, adoption in certain regions may require regulatory approval or adaptation to local clinical protocols, which could slow deployment in some healthcare systems.
Comparison with Other Tools
FeetMe competes with other wearable gait analysis solutions like Moticon, GaitUp, and SoleSound. Compared to Moticon, which focuses on pressure-sensing insoles primarily for sports and research, FeetMe provides real-time clinical feedback and AI-powered evaluation, making it more suitable for routine patient care.
GaitUp offers motion sensors attached to shoes or body segments, whereas FeetMe integrates sensors directly into insoles, offering a more seamless and user-friendly experience.
SoleSound combines motion tracking with acoustic data, which is innovative but less proven in clinical settings compared to FeetMe’s validated sensor suite and CE-marked platform.
FeetMe’s strong point is the combination of ease of use, clinical-grade data, and remote monitoring, positioning it as a complete solution for gait-focused rehabilitation and clinical assessment.
Customer Reviews and Testimonials
FeetMe has been featured in clinical research collaborations and health technology programs across Europe. While the website does not showcase individual user testimonials, the company has participated in major projects with hospitals, academic research groups, and public health agencies.
Feedback from practitioners highlights the system’s ease of integration into clinical workflows and the improved insight it provides into mobility impairments. Studies published using FeetMe’s platform have shown its effectiveness in tracking rehabilitation progress and detecting early signs of motor decline.
FeetMe has also received recognition from healthcare innovation events and has been supported by several European health innovation accelerators and grant programs.
Conclusion
FeetMe is transforming the way gait and mobility are assessed in clinical practice. Through its smart insole technology, the company offers an innovative, data-driven approach to rehabilitation, fall prevention, and movement disorder management.
By capturing high-quality biomechanical data in real-world settings, FeetMe empowers healthcare providers to make better, faster decisions that improve patient outcomes. Its ease of use, real-time monitoring, and remote assessment capabilities make it a valuable tool for modern healthcare systems focused on precision rehabilitation and preventative care.
For clinics, hospitals, and research institutions aiming to enhance mobility care and gait analysis without the limitations of traditional lab equipment, FeetMe presents a scalable and effective solution. Visit https://feetme.fr to learn more or request a demonstration.
